Gene: CRIP3
Official Full Name: cysteine rich protein 3provided by HGNC
Gene Summary: Predicted to enable metal ion binding activity. Predicted to act upstream of or within T cell proliferation. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21364 | CRIP3 Knockout cell line (HeLa) | Human | CRIP3 | 1:3~1:6 | Negative | Online Inquiry |
KO21365 | CRIP3 Knockout cell line (HEK293) | Human | CRIP3 | 1:3~1:6 | Negative | Online Inquiry |
KO21366 | CRIP3 Knockout cell line (A549) | Human | CRIP3 | 1:3~1:4 | Negative | Online Inquiry |
CRIP3 Gene Knockout Cell Lines are highly specialized cellular models engineered to lack the CRIP3 gene, which encodes for a protein involved in various biological processes, including immune regulation and cellular signaling. These versatile knockout models provide researchers with the ability to dissect the functional roles of CRIP3 in both physiological and pathological contexts. Through the targeted deletion of this gene, scientists can assess how its absence impacts cellular behavior, signaling pathways, and gene expression profiles.
The primary mechanism by which these cell lines operate is the CRISPR-Cas9 gene-editing technology, a revolutionary advancement that allows for precise modifications to be made in the genome of live cells. By creating a knockout of the CRIP3 gene, researchers can explore questions related to immune responses, cancer biology, and metabolic disorders, providing insights that are critical for both fundamental research and therapeutic development.
The scientific importance of CRIP3 Gene Knockout Cell Lines cannot be overstated; they are invaluable tools for investigating gene function and elucidating molecular mechanisms that underlie various diseases. In clinical and preclinical research settings, these models facilitate the evaluation of potential drug targets and biomarkers, thereby accelerating the discovery of novel therapeutic strategies.
Compared to traditional methods of gene silencing, such as RNA interference, CRIP3 Gene Knockout Cell Lines offer distinct advantages including permanent gene disruption, which ensures reproducibility and stability in experimental outcomes. Their precise genome editing minimizes off-target effects, yielding more reliable data for researchers striving to develop effective interventions.
Researchers and clinicians will find immense value in CRIP3 Gene Knockout Cell Lines, as they provide a refined platform for targeted investigations into the biological significance of CRIP3 and its role in health and disease. This resource exemplifies our commitment to advancing scientific knowledge and improving clinical outcomes through high-quality, innovative products.
Our company boasts extensive expertise in genetic engineering and molecular biology, underscoring our capability to deliver cutting-edge research tools that support scientific inquiry and foster advancements in biomedicine. We are dedicated to providing the resources that enable breakthroughs in research and ultimately enhance patient care.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.